trending Market Intelligence /marketintelligence/en/news-insights/trending/D22aqYdYo1kLSMjZlRoJpQ2 content esgSubNav
In This List

Madrigal Pharmaceuticals plans $100M common stock offering

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Madrigal Pharmaceuticals plans $100M common stock offering

Madrigal Pharmaceuticals Inc. is planning an underwritten public offering of $100 million worth of its common stock.

The company plans to grant the underwriters a 30-day option to buy up to an additional 15% of the shares offered.

Goldman Sachs & Co. LLC is the sole book runner of the offering.